Related Experiment Video
Updated: Aug 9, 2026
06:43
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
Margarines and coronary artery disease
1Department of Internal Medicine, Medical University of Southern Africa, Medunsa.
Medical Hypotheses
|April 1, 1992
Summary
Trans unsaturated fatty acids in foods like margarine promote high cholesterol. Supplementing with essential fatty acid metabolites may be prudent due to unavoidable dietary intake.
Area of Science:
- Nutrition Science
- Biochemistry
- Cardiovascular Health
Background:
- Dietary fat health effects understanding is prolonged.
- Trans unsaturated fatty acids (often in margarines) are linked to hypercholesterolemia.
- A reclassification of fats based on hypercholesterolemic properties is suggested.
Purpose of the Study:
- To highlight the adverse metabolic effects of trans fatty acids.
- To propose dietary recommendations considering trans fatty acid intake.
Main Methods:
- Review of existing research on trans fatty acids and human health.
- Analysis of the metabolic pathway involving delta-6-desaturase.
- Identification of common food sources high in trans fatty acids.
Main Results:
- Trans unsaturated fatty acids inhibit delta-6-desaturase, crucial for essential fatty acid metabolism.
- Margarines and many processed foods contain high levels of trans fatty acids.
- Consistent daily intake of trans fatty acids is nearly unavoidable.
Conclusions:
- Trans fatty acids in margarines and other foods pose a significant health risk.
- Dietary supplementation with delta-6-desaturase products is a prudent preventative measure.
- Understanding of dietary fat impacts requires ongoing research and public health advisories.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...